Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

KJ was born with a deficiency in an enzyme that breaks down ammonia, a by-product of protein digestion. He had to follow a ...

UCI Health — Irvine is making national history as the first all-electric acute care hospital in the United States. Instead of ...

Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they ...

USC biomedical engineers have found a way to make a solid tumor paint a target on its own back in order to train the body's ...

A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...

During today's call, I'll start with a brief overview of the product launches and foundational progress we made in 2024 and ...